Human mesangial cells express inducible macrophage scavenger receptor

Kidney International

Volumn 56, Issue 2, 1999, Pages 440-451

  Ruan, Xiong Z ^a   Varghese, Zac ^a   Powis, Stephen H ^a   Moorhead, John F ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerotic plaque; Foam cells; Gene transcription regulation; Glomerulosclerosis; Lipids

Indexed keywords

ANGIOTENSIN; CALMODULIN; LIPID; LOW DENSITY LIPOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN SERINE KINASE; SCAVENGER RECEPTOR; THREONINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; FOAM CELL; GENE EXPRESSION; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; LIPID TRANSPORT; MACROPHAGE; MESANGIUM CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA TRANSCRIPTION;

EID: 0032810368     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00587.x     Document Type: Article

References (32)

1. 1. GOLDSTEIN JL, HO YK, BASU SK, BROWN MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337, 1979
2. 2. STEINBRECHER UP, LOUGHEED M, KWAN WC, DIRKS M: Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J Biol Chem 264:15216-15223, 1989
3. 3. PARTHASARATHY S, PRINTZ DJ, BOYD D, JOY L, STEINBERG D: Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 6:505-510, 1986
4. 4. MATSUMOTO A, NAITO M, ITAKURA H, IKEMOTO S, ASAOKA H, HAYAKAWA I, KANAMORI H, ABURATANI H, TAKAKU F, SUZUKI H, KOBAR I, MIYAI T, TAKAHASHI K, COHEN EH, WYDRO R, HOUSMAN DE, KODAMA T: Human macrophage scavenger receptors: Primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 87:9133-9137, 1990
5. 5. ACTON SL, SCHERER PE, LODISH HF, KRIEGER M: Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 269:21003-21009, 1994
6. 6. NAITO M, KODAMA T, MATSUMOTO A, DOI T, TAKAHASHI K: Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am J Pathol 139:1411-1423, 1991
7. 7. KODAMA T, FREEMAN M, ROHRER L, ZABRECKY J, MATSUDAIRA P, KRIEGER M: Type I macrophage scavenger receptor contains a-helical and X collagen-like coiled coils. Nature 343:531-535, 1990
8. 8. NAITO M, SUZUKI H, MORI T, MATSUMOTO A, KODAMA T, TAKAHASHI K: Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 141:591-599, 1992
9. 9. FREEMAN M, EKKEL Y, ROHRER L, PENMAN M, FREEDMAN NJ, CHISOLM GM, KRIEGER M: Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc Natl Acad Sci USA 88:4931-4935, 1991
10. 10. GRÖNE EF, ABBOUD HE, HOHNE M, WALLI AK, GRONE HJ, STUKER D, ROBENEK H, WIELAND E, SEIDEL D: Actions of lipoproteins in cultured human mesangial cells: Modulation by mitogenic vasoconstrictors. Am J Physiol 263:F686-F696, 1992
11. 11. LEE HS, KOH HI: Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells. Lab Invest 71:200-208, 1994
12. 12. TAKEMURA T, YOSHIOKA K, AYA N, MURAKAMI K, MATUMOTO A, ITAKURA H, KODAMA T, SUZUKI H, MAKI S: Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43:918-927, 1993
13. 13. MOULTON KS, WU H, BARNETT J, PARTHASARATHY S, GLASS CK: Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences. Proc Natl Acad Sci USA 89:8102-8106, 1992
14. 14. WU H, MOULTON K, HORVAJ A, PARIK S, GLASS CK: Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol Cell Biol 14:2129-2139, 1994
15. 15. RUAN X, ARENDSHORST WJ: Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol 270:F945-F952, 1996
16. 16. BARNETT RL, RUFFINI L, RAMSAMMY L, PASMANTIER R, FRIEDLAENDER MM, NORD EP: cGMP antagonizes angiotensin-mediated phosphatidylcholine hydrolysis and C kinase activation in mesangial cells. Am J Physiol 268:C376-C381, 1995
17. 17. KEIDAR S: Angiotensin, LDL peroxidation and atherosclerosis. (review) Life Sci 63:1-11, 1998
18. 18. SRAER JD, DELARUE F, HAGEGE J, FEUNTEUN J, PINET F, NGUYEN G, RONDEAU E: Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int 49:267-270, 1996
19. 19. RUAN XZ, VARGHESE Z, FERNANDO R, MOORHEAD JF: Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 13:1391-1397, 1998
20. 20. FERNANDO RL, VARGHESE Z, MOORHEAD JF: Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro. Nephrol Dial Transplant 8:512-518, 1993
21. 21. INNERARITY TL, PITAS RE, MAHLEY RW: Lipoprotein-receptor interactions. Methods Enzymol 129:542-565, 1986
22. 22. ANDO M, GAFVELS M, BERGSTROM J, LINDHOLM B, LUNDKVIST I: Uremic serum enhances scavenger receptor expression and activity in the human monocytic cell line U937. Kidney Int 51:785-792, 1997
23. 23. VIA DP, PONS L, DENNISON DK, FANSLOW AE, BERNINI F: Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1. J Lipid Res 30:1515-1524, 1989
24. 24. ANDO M, LUNDKVIST I, BERGSTROM J, LINDHOLM B: Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int 49:773-780, 1996
25. 25. DIAMOND JR, KARNOVSKY MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. (review) Kidney Int 33:917-924, 1988
26. 26. KEANE WF, KASISKE BL, O'DONNELL MP: Lipids and progressive glomerulosclerosis: A model analogous to atherosclerosis. (review) Am J Nephrol 8:261-271, 1988
27. 27. MOORHEAD JF, CHAN MK, EL-NAHAS M, VARGHESE Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2:1309-1311, 1982
28. 28. HARRIS RC, MARTINEZ-MALDONADO M: Angiotensin II-mediated renal injury. (review) Miner Electrolyte Metab 21:328-335, 1995
29. 29. ADAMS JC, GULLICK WJ: Differences in phorbol-ester-induced down-regulation of protein kinase C between cell lines. Biochem J 257:905-911, 1989
30. 30. ANGEL P, KARIN M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. (review) Biochim Biophys Acta 1072:129-157, 1991
31. 31. PULVERER BJ, KYRIAKIS JM, AVRUCH J, NIKOLAKAKI E, WOODGETT JR: Phosphorylation of c-jun mediated by MAP kinases. Nature 353:670-674, 1991
32. 32. SMEAL T, BINETRUY B, MERCOLA DA, BIRRER M, KARIN M: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354:494-496, 1991